bemos, now that you are bullish instead of shorting it, you may feel the sting of your own techniques when they report lousy negative eps again.
do you mean to say you plan to borrow against your home to support the Kirkman and BOD retirement phase of this issue
seems like that's what the co is all about now and has been reduced to, either by bad luck or circumstance.
seems like golden parachutes all around. nothing cept an empty bag for us peasants.
I would not put the farm up Marty.
still waiting for an answer and if dndn provenge is already proven and nwbo's is possibly better with more antigens then why is nwbo's destined to fail. I submit if it does fail adam got lucky not much more than a guess but his logic of nwbi being a sure failure is helter skelter flawed imo/
no thanks, I don't short stocks and I am not saying its a good stock to short anyway, just saying the good is priced in and the risk of not delivering the high expectations is not.
this stock can not get over the hump largely because everything good is already pumped into it and anything negative such as continuing negative earnings is not. Thus we have a continuing situation of pump and dump.
I realize there are some who believe with conviction however the proof that they will become profitable any time soon is not there. and the high costs of production keep on coming on.
even if year over year revs increase they lose more money. last q was neg 21 cents eps the q before that a loss. next q the buuls say yeah yeah but when they report lousy eps again, it goes south waiting for that endless summer where things turn up but may not.
It was a great buy in the 2's but the hype is now priced in and the daytraders know it.
could be the cost structure is not as advantageous to actually making money as the bulls here think. maybe the more they make the more they lose. that's what the numbers point to as possibility. they lost another 21 cents eps last quarter on higher revenues.
the costs of maintaining the plants, the high costs of batteries, employee and executive compensations, the cost to make the cars versus a slower buildout could keep this co in the red a lot longer than the penny traders here who bought in the 2's and keep pumping about as they are trading it off on any pop.
them selling any ev's outside the support renting infrastructure staring in Hangzhou. That points to a slow buildout and raises the question about being profitable as soon or ever as the bulls state with high costs involved.. I have some doubts about that so remain sidelined but not short, not bashing.
cas, do you have to keep on bringing up pphm?
if you suspect nwbo is a pphm in the making why would you venture into it with such a large position?
it reminds of when weasl recently horted that stock vnda with a lot that almost tripled. these stocks can burn ya.
that said, I looked at imuc vs nwbo some and found someone's comment that imuc may have a responders in a class that can outlive that form of brain cancer due to methalayted mgmt. or something like that. everybody has an opinion, only the data will speak. I have some nwbo on some hope that those reduced tumors in animal studies that did not return does same thing in peeps. But I don't have that much belief in anything in this sector anymore. Its always something. my stock of no name shares are tacked up under the bridge for a someday maybe moment with ONT 10 or tecemotide but as we've seen these issues can be taken to the woodshed.
don't blame that one on me. It was you that brought the whole thing up with nwbo. I was accepting of my fate in this onty camp under the bridge but then you brought up the noise and chatter on nwbo, then that sa article came out comparing it to ONXX and that really is a weak spot with me, since I once held a lot of ONXX and got taken out in disappointment. But some arguments seem compelling on nwbo so I will hold the bag of a few nwbo shares and see how it plays out
why do you say you doubt they have a product when they have results of trials that say they do and tumor reductions are happening? can you read that "poses onyx like potential" article and comment?
from the above it seems the key goal is to reduce the tumor. If it works safely in achieving that then perhaps it would be considered a success in achieving its goal. sometimes tumors can choke off key arteries and can't be operated on. Reducing them could help people?
red, don't have a lot in nwbo but I got impressed by the sa article " poses onyx like potential". the guy made some interesting comparisons although he liked imuc also. if you get a chance look over that article and maybe post what you think about it..
thanks, I'm pretty much done. another stock of no name unless they show the market they are worth the trouble. will hold the bag awhile and see how it plays out.
yeah, I got caught up in it and pulled the trigger , bot 200 shares today in the 6;s only to see the news ah's. only thing is I'm glad I didn't buy a lot. but it is amazing the pump and dump happens as soon as I bot in. impeccable timing to the bag holder.
But then again, who nose, maybe it will be the next ONXX and maybe the stock offering won't be that terrible,
I dismissed this issue, nwbo, because I thought the therapy was too cumbersome, but the market disagrees. the sa article seemed to make a compelling buy side case and that stock has surged. That he compared it to ONXX in potential really got to me cause I once held ONXX and got discouraged after O15 failed only to see it soar later over the years on nexavar. Thus is the ying and yangery of the market view under the bridge. yes I am now in a few shares of nwbo along with this stock of no name. just in case. a few. some , not too much. probably be a bag holder again.
sine P1 and P1b is ongoing, there is a chance that they will continue to get responses that yield further tumor reductions. But they would need more of that to be considered in the way you are suggesting. As they enroll more patients and fine tune the procedures maybe they will see more. But until then, your scenario will take time to see if it can play out that way. yes a lady with ovarian cancer saw tumor reductions but they would need to see more people respond imo.
its a broad range of cancers in P1 and P1b. see the response in another post biomachine posted the links on the village. cant post links here but Ovarian looks to be a strong target for ONT 10 and I think they may go for others as well in P2 depending on the further results to come from p1, p1b.